drugs

Showing 15 posts of 771 posts found.

fda_building_web

Vernalis cough and cold drug knocked-back by FDA

August 7, 2017
Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma

Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …

original

Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline

August 4, 2017
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …

celgene_1_02

NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment

August 4, 2017
Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

chan_zuckerberg_initiative

Chan Zuckerberg Initiative injects $10 million into US big data healthcare project

August 4, 2017
Medical Communications, Research and Development Big Data, Chan Zuckerberg initiative, biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

brain-1845962_960_720

Diabetes drug holds promise to slow Parkinson’s progression

August 4, 2017
Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical

There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …

teva_canada

Teva releases financials, shares fall off cliff, plans to axe 7000 jobs

August 3, 2017
Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …

janssen_latest_logo_on_sign

FDA turns down Janssen’s sirukumab for rheumatoid arthritis

August 3, 2017
Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab

Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …

blood-75301_640

Existing arthritis drug could save thousands in blood cancer treatment

August 3, 2017
Research and Development University of Sheffield, arthritis, biotech, blood cancer, drugs, life sciences, medicine, pharma, pharmaceutical

Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …

4867472163_422821ed85_z

The common cold cured?

August 3, 2017
Research and Development biotech, cold, drugs, pharma, pharmaceutical, rhinovirus

Researchers from Edinburgh Napier University have discovered a crucial step in bringing forward a cure for the common cold. The …

gene_editing

Gene editing carried out, distances ‘designer baby’ possibility

August 3, 2017
Research and Development biotech, crispr, drugs, gene editing, pharma, pharmaceutical

The news broke last week that scientists in the US had carried out the first gene editing testing in the …

astrazeneca_logo_building

AstraZeneca’s Priority Review good news provides reprieve

August 2, 2017
Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical

If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …

Bicycle Therapeutics reveals new CFO

August 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, biotech, drugs, pharma, pharmaceutical

Bicycle Theapeutics, a biotech that is developing its bicyclic peptide product platform, has announced the appointed of Lee Kalowski as …

celgene_1_02

FDA approves Celgene and Agios’ acute myeloid leukaemia drug

August 2, 2017
Research and Development, Sales and Marketing Celgene, FDA, Idhifa, acute myeloid leukaemia, agios, biotech, drugs, life sciences, medicines, pharma, pharmaceuticals

The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …

The Gateway to Local Adoption Series

Latest content